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Multichannel electronic cell counters are now in widespread use in haematology
laboratories. Platelet counts are given routinely by many instruments and low
platelet counts generate much further investigation. A falsely low platelet count
may expose the patient to unnecessary and expensive investigation and treat-
ment, and we report two illustrative cases. The platelet counts were performed on
blood anticoagulated with ethylene diamine tetra acetate (EDTA) using a Coulter
S Plus IV analyser. Blood anticoagulated with 3-8% acid citrate dextrose was
analysed simultaneously. In the second case, platelet counts were also performed
on heparinised blood.
CASE 1. A 29
-year
- old primigravid female in good general health was
referred for haematological assessment during the first trimester of pregnancy.
Her platelet count has been reported as 18 x 109/1 on two occasions (normal
150-400 x 109/1. There was no history of a bleeding tendency and exam-
ination revealed no abnormalities, in particular there was no purpura or bruising.
The platelet count was rechecked using EDTA (20 x 109/1) and citrate
(30 x 109/1). Other blood parameters were normal. Platelet antibodies were not
detected. Bone marrow aspirate and trephine biopsy were normal. A diagnosis of
idiopathic thrombocytopenic purpura was made and therapy with prednisolone
60 mg per day was started but there was no rise in the platelet count. A five day
course of intravenous immunoglobulin [400 kg/day] was given, also without
effect.
Pregnancy proceeded normally, the steroid dosage being gradually reduced
and at full term a normal girl was delivered. One month post partum the
mother's platelet count was 18 x 109/1 in EDTA and 194 x 109/1 in citrate.
Three months post partum her platelet count was 76 x 109/1 in EDTA and
253 x 109/1 in citrate.
CASE 2. A 29-year -old male was referred for investigation of an incidental
finding ofthrombocytopenia. Platelet count ranged between 25 and 83 x 109/1
(all in EDTA). He felt well with no evidence of purpura or bruising. All other
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haematological and biochemical parameters were within normal limits. Platelet
antibodies were not detected. Bone marrow aspirate showed numerous mega-
karyocytes and a diagnosis of idiopathic thrombocytopenic purpura was made.
He was treated with prednisolone 60 mg/day for 10 days subsequently reducing
to 40 mg daily. After 14 days the platelet count remained 76 x 109/1. Prednis-
olone was reduced to 30 mg/day. Steroid dosage reduction continued and
vitamin C 2 g daily was started. Sixweeks later prednisolone was discontinued but
the platelet count remained 78 x 109/1. He was advised to avoid contact sports
and to continue vitamin C 2 g daily.
At review three months later his platelet count in EDTA remained 30 x 109/1.
There was no evidence of excessive bruising. Two courses of intravenous
immunoglobulin, 90g/day for two days and 35g/day for five days were given
without benefit. Consideration was being given to splenectomy because of the
failure to respond to steroids and immunoglobulin. Viral studies were unhelpful.
At this stage the platelet count was checked in citrate, (34 x 109/1) and heparin
(154 x 109/1). Examination of a peripheral blood film showed adequate
numbers of platelets. A diagnosis of pseudothrombocytopenia was made and all
medication stopped. On two subsequent occasions the platelet count remained
low in EDTA and citrate but normal in heparin.
DISCUSSION
Both these cases were initially diagnosed to have idiopathic thrombocytopenia,
but it later became clear that the haematological reports represented a pseudo-
thrombocytopenic state. This is an in vitro artefact with no clinical effect. In a
large survey Vicaril found an incidence ofpseudothrombocytopenia of 0* 13% in
33,623 subjects referred from a general hospital. The commonest cause of this
artefact is platelet clumping in EDTA. Thisis thought to be dueto the reaction of
platelet specific antibodies with platelets in the presence ofEDTA.2 Van Vliet3 has
shown the presence of an IgM autoantibody in these patients which reacts with
the GpIIb/ Illa complex on the platelet surface in the presence of EDTA. Platelet
aggregation in citrate has also been described.4,5
In Case 1 the platelet count in citrate was normal after pregnancy, but low during
pregnancy. There are two possible explanations for this - either the platelet
count during pregnancy wasincorrect [duetotechnical factors suchas insufficient
citrate in the bottle or small clots being present] or else the platelet autoantibody
was active in citrate during pregnancy only. In either case an earlier recognition of
this artefact would have spared the patient unnecessary, expensive and possibly
hazardous therapy. There are reports of patients with pseudothrombocytopenia
having splenectomy for a misdiagnosis ofidiopathic thrombocytopenic purpura.4
It is essential therefore to be sceptical about platelet counts that do not correlate
with the clinical history and findings. Most cases of pseudothrombocytopenia will
be uncovered if a well-made peripheral blood smear is examined to see if the
number of platelets present in the film correlates with the stated platelet count.
In pseudothrombocytopenia platelet clumps will be seen if a film is made from
blood exposed to EDTA. It is also useful to measure platelet counts in both EDTA
and citrate samples simultaneously, as this will usually, but not always, (as in
Case 2) raise the suspicion. The latter case demonstrated clumping in citrate as
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well as EDTA, and a true platelet count could only be obtained froma heparinised
sample. It is now routine practice in this laboratory to recheck all low platelet
counts in heparin as well as citrate.
Both cases illustrate the importance of assessing the patient clinically. Neither
patient had evidence of bleeding. Asymptomatic patients should not be treated
aggressively with steroids or immunoglobulin. One should treat the patient and
not the platelet count.
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